The genetic basis of long QT and short QT syndromes: a mutation update - Wikidata - wikimedia - TriplyDB

The genetic basis of long QT and short QT syndromes: a mutation update

The genetic basis of long QT and short QT syndromes: a mutation update

http://www.wikidata.org/entity/Q28262724

about

Cellular mechanisms of mutations in Kv7.1: auditory functions in Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death Cases Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling Impact of New Genomic Technologies on Understanding Adverse Drug Reactions iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction Molecular pathogenesis of long QT syndrome type 1 Leptin decreases heart rate associated with increased ventricular repolarization via its receptor Automatic filtering and substantiation of drug safety signals Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants AfroDb: a select highly potent and diverse natural product library from African medicinal plants Molecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling.An in silico evaluation of the ADMET profile of the StreptomeDB database.In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin.Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids.Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.Assessing QT interval prolongation and its associated risks with antipsychotics.Electrophysiological study of V535M hERG mutation of LQT2.KCNH2 gene mutation: a potential link between epilepsy and long QT-2 syndrome.Long QT syndrome in South Africa: the results of comprehensive genetic screening.New iPSC for old long QT syndrome modeling: putting the evidence into perspective.Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.RNA interference-based therapeutics for inherited long QT syndrome Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.Structural interplay of KV7.1 and KCNE1 is essential for normal repolarization and is compromised in short QT syndrome 2 (KV7.1-A287T).The EGFP/hERG fusion protein alter the electrophysiological properties of hERG channels in HEK293 cells.A novel KCNQ1 nonsense variant in the isoform-specific first exon causes both jervell and Lange-Nielsen syndrome 1 and long QT syndrome 1: a case report Antiparasitic Sesquiterpenes from the Cameroonian Spice Scleria striatinux and Preliminary In Vitro and In Silico DMPK Assessment.Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules Drug-induced QT interval prolongation: mechanisms and clinical management Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide.An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.Systems pharmacology of arrhythmias Location, location, regulation: a novel role for β-spectrin in the heart.High prevalence of genetic variants previously associated with LQT syndrome in new exome data KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients.Human-induced pluripotent stem cells: in quest of clinical applications.Ion channel associated diseases: overview of molecular mechanisms

P2860

Q24320059-6C46EADA-213F-45C7-AA36-8A5E6EEF152A Q26745883-92FBBE82-2B8A-487A-899C-2685E04CB876 Q26750618-1FB49430-53D6-4B06-9E08-B6806BA32E17 Q26787099-F439E3C7-4680-4307-B243-4A2BE6D85621 Q26865055-DFE13080-FC3C-41CC-AD86-DEFEFB16B5F4 Q27322725-B41FC66E-8555-4569-BF8E-B30212E03B7D Q28069279-2C7DCE21-641F-4ACF-AE68-0C224D0D31AD Q28395369-E22690C3-CDFD-4760-82A3-350830FC1DC5 Q28482131-641B5B90-D4C7-4537-A26B-08D2EA4B2A05 Q28484309-33BB529C-C33D-4C28-88B0-45BDDBD11896 Q28534724-50A74991-802B-4B3A-9CC3-DADC6392551C Q28548072-A303BB47-A835-4089-8293-AB9538E5DEC7 Q28552684-5B67B7F4-79A3-4F4F-8A4F-E338FC697BD7 Q30315979-0BB43B2F-414A-400A-ACDC-BB7022EB104A Q30317740-ED7A0F53-CED6-4FA6-8B37-C062ED5741A4 Q30317914-D4811154-566C-4C08-B09F-B36896E1F8E4 Q30394930-F9167D15-07DA-4876-83BF-1A48CA6F5B7E Q31153701-F85B0EA8-1EB8-4C2B-B8DE-99BCF2E6E0B8 Q33160123-A14B6B17-F4E9-42C3-BEF2-B3C9C7FD6AB0 Q33160777-E2EEB451-DC49-4445-9B76-4E2A85B0D236 Q33161213-75422F56-8554-47C4-9B89-FE537699F375 Q33163516-BFF1C9AB-76B5-4762-A511-5F1CD38BCCC5 Q33163663-94610542-BD37-4E49-84CA-4D74816703D5 Q33166274-6FAF428E-0270-4D5B-B644-0DB78BFDBC3C Q33166507-F44DEA96-E142-4E61-8C04-5E06DCC4BAA0 Q33625684-C578704F-2FBE-4935-95B8-2EC40CC527DF Q33644389-E1404323-9084-482C-8139-E893BC46FD3D Q33766430-BBDA90B2-16A2-41F6-9174-676042F185FE Q33781672-43E39889-B941-4FD5-9721-4C9516BCD074 Q33825850-783BBA50-A962-4552-9E00-BD8733487992 Q33859184-995D7BBF-1339-4C93-9FBC-E2946A7C292B Q33949538-13D5AEB9-5C6B-4AF1-9A5E-975F9EB2557A Q33976419-26E588A2-FD9E-418A-9A34-B6C3ADD1543A Q34000857-1D6029D0-4294-4EAE-BE30-2F6E9CAA1192 Q34111154-834E413D-433E-4BE0-976C-1B86820B2217 Q34162722-BB9662D8-6BDB-4431-9AA7-652C74F66B0D Q34179377-065641D9-8E8C-4186-A1AE-14303686F6FE Q34222729-A5EBB37A-74E5-4436-AA99-FCAF145FF6CA Q34251675-C6C4A2E9-B062-4968-8792-633D2C27A6E1 Q34311621-FF493EC7-B1D9-4493-A72D-31AD0AF91248

P2860

The genetic basis of long QT and short QT syndromes: a mutation update

http://www.wikidata.org/entity/Q28262724

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The genetic basis of long QT and short QT syndromes: a mutation update

@ast

The genetic basis of long QT and short QT syndromes: a mutation update

@en

The genetic basis of long QT and short QT syndromes: a mutation update

@nl

type

label

The genetic basis of long QT and short QT syndromes: a mutation update

@ast

The genetic basis of long QT and short QT syndromes: a mutation update

@en

The genetic basis of long QT and short QT syndromes: a mutation update

@nl

prefLabel

The genetic basis of long QT and short QT syndromes: a mutation update

@ast

The genetic basis of long QT and short QT syndromes: a mutation update

@en

The genetic basis of long QT and short QT syndromes: a mutation update

@nl

P1433

Q28262724-991E3281-4420-447B-A0B5-FF8921829E7B

P1476

Q28262724-54B8B810-C862-46FD-BCAA-C154EFD7A50E

P2093

Q28262724-168C8885-B568-4364-95C6-0B422D97210A

Q28262724-6B22959B-62DB-4134-903C-E0CEEC4B58D6

Q28262724-71B75B13-DF1D-4801-A36F-A6D29ED2E890

Q28262724-9843C0EF-63DF-4683-AFA2-37D780BF3177

Q28262724-AC82D673-A5C8-42FA-8002-14C77D1FF594

Q28262724-AFD688C4-21E3-4FCD-8DC5-F2DB31DECAF5

Q28262724-D60BF123-0DA5-4218-ACB5-EE656539946A

Q28262724-F6E2B8C2-1EB3-4C00-BE9C-5F6B8EAB5F39

P304

Q28262724-1A44E8CD-685D-4308-83AA-C01EFB2390A9

P31

Q28262724-4E0E464F-C2AF-4985-BC53-C2610C950FF6

P3181

Q28262724-B69ED422-C960-43B9-B0CE-462BAA271A57

P356

Q28262724-7701A7C4-7741-44E0-9DBF-908525E97184

P407

Q28262724-2D455A69-C28A-4EA3-BF0B-ABF1CEA97823

P433

Q28262724-74CAC4D3-AF8A-4BFB-960A-95AD51CFB167

P478

Q28262724-241EA71F-4AB6-468F-85A0-A932F7BB770B

P50

Q28262724-4B6AFFDD-D123-4492-875B-12C3C4BEC882

P577

Q28262724-C84115F5-376F-4AF1-AF31-44F2E2F34804

P5875

Q28262724-8373ACEC-ACBC-4D79-925F-01A933F34046

P698

Q28262724-C1C427D7-F59C-4E12-937C-D3C400DA7913

P3181

P356

P1433

P1476

The genetic basis of long QT and short QT syndromes: a mutation update

@en

P2093

Johanna Moolman-Smook

http://www.w3.org/2001/XMLSchema#string

Jørgen K Kanters

http://www.w3.org/2001/XMLSchema#string

Michael Christiansen

http://www.w3.org/2001/XMLSchema#string

Paul A Brink

http://www.w3.org/2001/XMLSchema#string

Poul Jørgensen

http://www.w3.org/2001/XMLSchema#string

Romilda Wangari

http://www.w3.org/2001/XMLSchema#string

Sarah Schlamowitz

http://www.w3.org/2001/XMLSchema#string

Valerie A Corfield

http://www.w3.org/2001/XMLSchema#string

P304

1486-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

478859

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HUMU.21106

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Paula Louise Hedley

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38041951

http://www.w3.org/2001/XMLSchema#string

P698

19862833

http://www.w3.org/2001/XMLSchema#string